Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Two thirds of patients with Crohn's disease require intestinal surgery at some time in their
life. Intestinal strictures, that is narrowing of the bowel due to inflammation and scarring,
are the most common reason for surgery. Despite the high frequency, associated disability,
and cost there are no are no treatment strategies that aim to improve the outcome of this
disease complication. The STRIDENT (stricture definition and treatment) studies aim to
develop such strategies.
Phase:
Phase 4
Details
Lead Sponsor:
St Vincent's Hospital Melbourne
Collaborators:
AbbVie Australasian Gastro Intestinal Research Foundation